Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Swiss Group for Clinical Cancer Research
Woman and Man Max 99 years
Swiss Group for Clinical Cancer Research SAKK
Update Il y a 4 ans
Protocol SAKK 77/06 and SASL 23 Continuous sunitinib treatment in patients with unresectable hepatocellular carcinoma A multicenter phase II trial
To demonstrate antitumor activity of continuous sunitinib (Sutent®) treatment in patients with unresectable hepatocellular carcinoma.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
SAKK Swiss Group for Clinical Cancer Research
Update Il y a 4 ans
Neoadjuvant radiotherapy and capecitabine with or without panitumumab in patients with advanced, K-ras unmutated rectal cancer. A randomized multicenter phase II trial
To assess the efficacy and safety of the neoadjuvant regimen of capecitabine and external beam radiotherapy in combination with panitumumab in patients with advanced K-ras unmutated rectal cancer.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
SAKK Swiss Group for Clinical Cancer Research
Update Il y a 4 ans
Adjuvant aspirin treatment in PIK3CA mutated colon cancer patients PIK3CA mutációs vastagbélrákban szenvedő betegek kiegészítő aszpirin kezelése
The objective of the trial is to demonstrate a statistically significant and clinically relevant disease free survival benefit in stage II and III PIK3CA mutated colon cancer patients taking daily adj...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Swiss Group for Clinical Cancer Research SAKK
Update Il y a 4 ans
Rituximab with or without Ibrutinib for untreated patients with advanced follicular lymphoma in need of therapy
The objective of this trial is to study the activity and the safety of the 1st line treatment with Ibrutinib in combination with Rituximab for patients with advanced follicular lymphoma in need of the...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man
Between 18 years
and 99 years
Swiss Group for Clinical Cancer Research
Update Il y a 4 ans
SWS-SAKK56/07 : Essai de phase 2 évaluant l'efficacité et la tolérance du dasatinib en traitement de 1ère ligne chez des patients ayant une tumeur stromale gastro-intestinale (GIST). [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
Dasatinib first-line treatment in gastrointestinal stromal tumors. A multi center phase II trial.
Country
France
organs
Tumeurs stromales digestives (GIST)
Specialty
Thérapies Ciblées
Essai clos aux inclusions
More information
Woman and Man
Between 18 years
and 99 years
Swiss Group for Clinical Cancer Research
Update Il y a 4 ans
Essai de phase 2 évaluant l'efficacité de l'everolimus, chez des patients ayant un lymphome à cellules du manteau en rechute ou résistant aux traitements. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
Master Protocol for Mantle Cell Lymphoma A Multicenter Phase II Trial Testing Everolimus (RAD001) for the Treatment of Patients With Relapsed or Therapy Resistant Mantle Cell Lymphoma.
Country
France
organs
Lymphomes non hodgkinien
Specialty
Chimiothérapie
Essai clos aux inclusions
More information
Woman and Man Max 99 years
SAKK Swiss Group for Clinical Cancer Research
Update Il y a 4 ans
Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced, K-ras mutated rectal cancer. A randomized multicenter phase I/II trial
Part I: to determine the recommended dose of the neoadjuvant regimen of capecitabine, sorafenib and external beam radiotherapy in patients with advanced K-ras mutated rectal cancer. Part IIa: to asses...
Country
None
organs
None
Specialty
None
unknown
More information
Man Max 99 years
Swiss Group for Clinical Cancer Research SAKK
Update Il y a 4 ans
Carboplatin chemotherapy and involved node radiotherapy in stage IIA/B seminoma
The main objective of this trial is to test the efficacy and safety of carboplatin chemotherapy and involved node radiotherapy in patients with stage IIA/B seminoma.
Country
None
organs
None
Specialty
None
unknown
More information